{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:20:12Z","timestamp":1793974812179,"version":"4.8.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100013053","name":"Hotchkiss Brain Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003206","name":"Alberta Children's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1196508"],"award-info":[{"award-number":["1196508"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1150083"],"award-info":[{"award-number":["1150083"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1196508"],"award-info":[{"award-number":["1196508"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1150083"],"award-info":[{"award-number":["1150083"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1038\/s41380-025-02935-z","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T02:47:56Z","timestamp":1739760476000},"page":"3491-3501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes"],"prefix":"10.1038","volume":"30","author":[{"given":"Nazanin","family":"Vaziri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Shutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0388-1248","authenticated-orcid":false,"given":"Wasi","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Raedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9565-0238","authenticated-orcid":false,"given":"Christos","family":"Pantelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5352-1075","authenticated-orcid":false,"given":"Mahesh","family":"Jayaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Greenway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-8696","authenticated-orcid":false,"given":"Chad A.","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"2935_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/0957154X07070335","volume":"18","author":"J Crilly","year":"2007","unstructured":"Crilly J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry. 2007;18:39\u201360.","journal-title":"Hist Psychiatry"},{"key":"2935_CR2","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","volume":"158","author":"M Chakos","year":"2001","unstructured":"Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry. 2001;158:518\u201326.","journal-title":"Am J Psychiatry"},{"key":"2935_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","volume":"374","author":"J Tiihonen","year":"2009","unstructured":"Tiihonen J, L\u00f6nnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374:620\u20137.","journal-title":"Lancet"},{"key":"2935_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000507638","volume":"89","author":"J de Leon","year":"2020","unstructured":"de Leon J, Ruan C-J, Schoretsanitis G, De las Cuevas C. A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom. 2020;89:200\u201314.","journal-title":"Psychother Psychosom"},{"key":"2935_CR5","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMra0800028","volume":"360","author":"LT Cooper","year":"2009","unstructured":"Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526\u201338.","journal-title":"N Engl J Med"},{"key":"2935_CR6","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/14740338.2016.1191468","volume":"15","author":"G Remington","year":"2016","unstructured":"Remington G, Lee J, Agid O, Takeuchi H, Foussias G, Hahn M, et al. Clozapine\u2019s critical role in treatment resistant schizophrenia: ensuring both safety and use. Expert Opin Drug Saf. 2016;15:1193\u2013203.","journal-title":"Expert Opin Drug Saf"},{"key":"2935_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijcard.2017.12.102","volume":"259","author":"BL Bellissima","year":"2018","unstructured":"Bellissima BL, Tingle MD, Cicovi\u0107 A, Alawami M, Kenedi C. A systematic review of clozapine-induced myocarditis. Int J Cardiol. 2018;259:122\u20139.","journal-title":"Int J Cardiol"},{"key":"2935_CR8","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.schres.2023.09.039","volume":"261","author":"N Vaziri","year":"2023","unstructured":"Vaziri N, Marques D, Greenway SC, Bousman CA. The cellular mechanism of antipsychotic-induced myocarditis: a systematic review. Schizophr Res. 2023;261:206\u201315.","journal-title":"Schizophr Res"},{"key":"2935_CR9","unstructured":"Bousman C, Greenway SC, Tarailo-Graovac M, Long Q, Sellmer R, Crockford D, et al. editors. The pharmacogenomics of clozapine-induced myocarditis (PROCLAIM) consortium. Neuropsychopharmacology. 2018: Nature publishing group macmillan building, 4, England."},{"key":"2935_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/00048674.2011.572852","volume":"45","author":"KJ Ronaldson","year":"2011","unstructured":"Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry. 2011;45:458\u201365.","journal-title":"Aust N Z J Psychiatry"},{"key":"2935_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-62703-511-8_7","volume":"1036","author":"JM Churko","year":"2013","unstructured":"Churko JM, Burridge PW, Wu JC. Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol. 2013;1036:81\u20138.","journal-title":"Methods Mol Biol"},{"key":"2935_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2022.102877","volume":"63","author":"N Vaziri","year":"2022","unstructured":"Vaziri N, Marques D, Wang X, Machiraju P, Narang A, Vlahos K, et al. Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia. Stem Cell Res. 2022;63:102877.","journal-title":"Stem Cell Res"},{"key":"2935_CR13","doi-asserted-by":"crossref","unstructured":"Machiraju P, Huang J, Iqbal F, Liu Y, Wang X, Bousman C, et al. Early inhibition of retinoic acid signaling rapidly generates cardiomyocytes expressing ventricular markers from human induced pluripotent stem cells. bioRxiv. 2019:856575.","DOI":"10.1101\/856575"},{"key":"2935_CR14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/cr.2010.163","volume":"21","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Jiang J, Han P, Yuan Q, Zhang J, Zhang X, et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 2011;21:579\u201387.","journal-title":"Cell Res"},{"key":"2935_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.taap.2004.03.016","volume":"199","author":"K Titier","year":"2004","unstructured":"Titier K, Canal M, D\u00e9ridet E, Abouelfath A, Gromb S, Molimard M, et al. Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol. 2004;199:52\u201360.","journal-title":"Toxicol Appl Pharmacol"},{"key":"2935_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51:9\u201362.","journal-title":"Pharmacopsychiatry"},{"key":"2935_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fncel.2017.00119","volume":"11","author":"J Wu","year":"2017","unstructured":"Wu J, Hao S, Sun X-R, Zhang H, Li H, Zhao H, et al. Elamipretide (SS-31) ameliorates isoflurane-induced long-term impairments of mitochondrial morphogenesis and cognition in developing rats. Front Cell Neurosci. 2017;11:119.","journal-title":"Front Cell Neurosci"},{"key":"2935_CR18","doi-asserted-by":"publisher","first-page":"15363","DOI":"10.1073\/pnas.2002250117","volume":"117","author":"JD Chavez","year":"2020","unstructured":"Chavez JD, Tang X, Campbell MD, Reyes G, Kramer PA, Stuppard R, et al. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci. 2020;117:15363\u201373.","journal-title":"Proc Natl Acad Sci"},{"key":"2935_CR19","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/bph.12461","volume":"171","author":"HH Szeto","year":"2014","unstructured":"Szeto HH. First\u2010in\u2010class cardiolipin\u2010protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171:2029\u201350.","journal-title":"Br J Pharmacol"},{"key":"2935_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fcvm.2019.00167","volume":"6","author":"P Machiraju","year":"2019","unstructured":"Machiraju P, Wang X, Sabouny R, Huang J, Zhao T, Iqbal F, et al. SS-31 peptide reverses the mitochondrial fragmentation present in fibroblasts from patients with DCMA, a mitochondrial cardiomyopathy. Front Cardiovasc Med. 2019;6:167.","journal-title":"Front Cardiovasc Med"},{"key":"2935_CR21","first-page":"554","volume":"36","author":"L Rohani","year":"2020","unstructured":"Rohani L, Machiraju P, Sabouny R, Meng G, Liu S, Zhao T, et al. Reversible mitochondrial fragmentation in iPSC-derived cardiomyocytes from children with DCMA, a mitochondrial cardiomyopathy. Can J Cardiol. 2020;36:554\u201363.","journal-title":"Can J Cardiol"},{"key":"2935_CR22","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14740338.2023.2278686","volume":"23","author":"J Chetwood","year":"2024","unstructured":"Chetwood J, Gupta S, Subramaniam K, De Cruz P, Moore G, An Y, et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis\u2013national extended follow-up and a review of the literature. Expert Opin Drug Saf. 2024;23:449\u201356.","journal-title":"Expert Opin Drug Saf"},{"key":"2935_CR23","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/intimm\/dxl046","volume":"18","author":"KS Gorski","year":"2006","unstructured":"Gorski KS, Waller EL, Bjornton-Severson J, Hanten JA, Riter CL, Kieper WC, et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol. 2006;18:1115\u201326.","journal-title":"Int Immunol"},{"key":"2935_CR24","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1161\/CIRCRESAHA.117.312067","volume":"122","author":"L Sala","year":"2018","unstructured":"Sala L, Van Meer BJ, Tertoolen LG, Bakkers J, Bellin M, Davis RP, et al. MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circ Res. 2018;122:e5\u2013e16.","journal-title":"Circ Res"},{"key":"2935_CR25","doi-asserted-by":"publisher","first-page":"32608","DOI":"10.1074\/jbc.273.49.32608","volume":"273","author":"M Garcia-Calvo","year":"1998","unstructured":"Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998;273:32608\u201313.","journal-title":"J Biol Chem"},{"key":"2935_CR26","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12012-021-09632-7","volume":"21","author":"F Zhang","year":"2021","unstructured":"Zhang F, Han L, Wang J, Shu M, Liu K, Zhang Y, et al. Clozapine induced developmental and cardiac toxicity on Zebrafish Embryos by elevating oxidative stress. Cardiovasc Toxicol. 2021;21:399\u2013409.","journal-title":"Cardiovasc Toxicol"},{"key":"2935_CR27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.toxrep.2014.11.012","volume":"1","author":"BA Abdel-Wahab","year":"2014","unstructured":"Abdel-Wahab BA, Metwally ME. Clozapine-induced cardiotoxicity in rats: involvement of tumour necrosis factor alpha, NF-\u03ba\u03b2 and caspase-3. Toxicol Rep. 2014;1:1213\u201323.","journal-title":"Toxicol Rep"},{"key":"2935_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s12012-014-9304-9","volume":"15","author":"BA Abdel-Wahab","year":"2015","unstructured":"Abdel-Wahab BA, Metwally ME. Clozapine-induced cardiotoxicity: role of oxidative stress, tumour necrosis factor alpha and NF-\u03ba\u03b2. Cardiovasc Toxicol. 2015;15:355\u201365.","journal-title":"Cardiovasc Toxicol"},{"key":"2935_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/schbul\/sbu120","volume":"41","author":"RD Hayes","year":"2015","unstructured":"Hayes RD, Downs J, Chang C-K, Jackson RG, Shetty H, Broadbent M, et al. The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders. Schizophr Bull. 2015;41:644\u201355.","journal-title":"Schizophr Bull"},{"key":"2935_CR30","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/YIC.0b013e32819f8f17","volume":"22","author":"B Yusufi","year":"2007","unstructured":"Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, et al. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol. 2007;22:238\u201343.","journal-title":"Int Clin Psychopharmacol"},{"key":"2935_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/YIC.0000000000000169","volume":"32","author":"BM Nilsson","year":"2017","unstructured":"Nilsson BM, Edstr\u00f6m O, Lindstr\u00f6m L, Wernegren P, Bod\u00e9n R. Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections. Int Clin Psychopharmacol. 2017;32:219\u201324.","journal-title":"Int Clin Psychopharmacol"},{"key":"2935_CR32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1536\/ihj.35.745","volume":"35","author":"H Kawano","year":"1994","unstructured":"Kawano H, Okada R, Kawano Y, Sueyoshi N, Shirai T. Apoptosis in acute and chronic myocarditis. Jpn Heart J. 1994;35:745\u201350.","journal-title":"Jpn Heart J"},{"key":"2935_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.cpcardiol.2005.11.002","volume":"31","author":"TM Scarabelli","year":"2006","unstructured":"Scarabelli TM, Knight R, Stephanou A, Townsend P, Chen-Scarabelli C, Lawrence K, et al. Clinical implications of apoptosis in ischemic myocardium. Curr Probl Cardiol. 2006;31:181\u2013264.","journal-title":"Curr Probl Cardiol"},{"key":"2935_CR34","first-page":"8B","volume":"15","author":"P Liu","year":"1999","unstructured":"Liu P, Sole MJ. What is the relevance of apoptosis to the myocardium? Can J Cardiol. 1999;15:8B\u201310B.","journal-title":"Can J Cardiol"},{"key":"2935_CR35","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1110\/ps.04789804","volume":"13","author":"Y Shi","year":"2004","unstructured":"Shi Y. Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci. 2004;13:1979\u201387.","journal-title":"Protein Sci"},{"key":"2935_CR36","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/sj.npp.1301074","volume":"32","author":"LF Jarskog","year":"2007","unstructured":"Jarskog LF, Gilmore JH, Glantz LA, Gable KL, German TT, Tong RI, et al. Caspase-3 activation in rat frontal cortex following treatment with typical and atypical antipsychotics. Neuropsychopharmacology. 2007;32:95\u2013102.","journal-title":"Neuropsychopharmacology"},{"key":"2935_CR37","first-page":"593","volume":"136","author":"M Arends","year":"1990","unstructured":"Arends M, Morris R, Wyllie A. Apoptosis. The role of the endonuclease. Am J Pathol. 1990;136:593.","journal-title":"Am J Pathol"},{"key":"2935_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/S0896-6273(03)00601-9","volume":"40","author":"J Yuan","year":"2003","unstructured":"Yuan J, Lipinski M, Degterev A. Diversity in the mechanisms of neuronal cell death. Neuron. 2003;40:401\u201313.","journal-title":"Neuron"},{"key":"2935_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/ars.2021.0145","volume":"36","author":"DdL Scheffer","year":"2022","unstructured":"Scheffer DdL, Garcia AA, Lee L, Mochly-Rosen D, Ferreira JCB. Mitochondrial fusion, fission, and mitophagy in cardiac diseases: challenges and therapeutic opportunities. Antioxid Redox Signal. 2022;36:844\u201363.","journal-title":"Antioxid Redox Signal"},{"key":"2935_CR40","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1046\/j.1471-4159.2002.01263.x","volume":"83","author":"D Ben\u2010Shachar","year":"2002","unstructured":"Ben\u2010Shachar D. Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem. 2002;83:1241\u201351.","journal-title":"J Neurochem"},{"key":"2935_CR41","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0361-9230(01)00528-7","volume":"55","author":"N Uranova","year":"2001","unstructured":"Uranova N, Orlovskaya D, Vikhreva O, Zimina I, Kolomeets N, Vostrikov V, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597\u2013610.","journal-title":"Brain Res Bull"},{"key":"2935_CR42","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1080\/01926230290166724","volume":"30","author":"R Kohen","year":"2002","unstructured":"Kohen R, Nyska A. Invited review: oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol. 2002;30:620\u201350.","journal-title":"Toxicol Pathol"},{"key":"2935_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11357-016-9933-y","volume":"38","author":"B Mart\u00edn-Fern\u00e1ndez","year":"2016","unstructured":"Mart\u00edn-Fern\u00e1ndez B, Gredilla R. Mitochondria and oxidative stress in heart aging. Age. 2016;38:225\u201338.","journal-title":"Age"},{"key":"2935_CR44","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1007\/s00210-021-02095-1","volume":"394","author":"AA Hafez","year":"2021","unstructured":"Hafez AA, Jamali Z, Khezri S, Salimi A. Thymoquinone reduces mitochondrial damage and death of cardiomyocytes induced by clozapine. Naunyn Schmiedebergs Arch Pharmacol. 2021;394:1675\u201384.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2935_CR45","doi-asserted-by":"publisher","first-page":"741861","DOI":"10.1100\/2012\/741861","volume":"2012","author":"P Mishra","year":"2012","unstructured":"Mishra P, Samanta L. Oxidative stress and heart failure in altered thyroid states. Sci World J. 2012;2012:741861.","journal-title":"Sci World J"},{"key":"2935_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007;39:44\u201384.","journal-title":"Int J Biochem Cell Biol"},{"key":"2935_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/00498254.2023.2294473","volume":"54","author":"E Kingston","year":"2024","unstructured":"Kingston E, Tingle M, Bellissima BL, Helsby N, Burns K. CYP-catalysed cycling of clozapine and clozapine-N-oxide promotes the generation of reactive oxygen species in vitro. Xenobiotica. 2024;54:26\u201337.","journal-title":"Xenobiotica"},{"key":"2935_CR48","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/acel.12102","volume":"12","author":"MP Siegel","year":"2013","unstructured":"Siegel MP, Kruse SE, Percival JM, Goh J, White CC, Hopkins HC, et al. Mitochondrial\u2010targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice. Aging Cell. 2013;12:763\u201371.","journal-title":"Aging Cell"},{"key":"2935_CR49","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1007\/s10753-019-01081-3","volume":"42","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yang W, Sun X, Xie L, Yang Y, Sang M, et al. SS31 ameliorates sepsis-induced heart injury by inhibiting oxidative stress and inflammation. Inflammation. 2019;42:2170\u201380.","journal-title":"Inflammation"},{"key":"2935_CR50","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","volume":"41","author":"S-Y Jeong","year":"2008","unstructured":"Jeong S-Y, Seol D-W. The role of mitochondria in apoptosis. BMB Rep. 2008;41:11\u201322.","journal-title":"BMB Rep"},{"key":"2935_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01018-7","volume":"7","author":"L Li","year":"2022","unstructured":"Li L, Gao P, Tang X, Liu Z, Cao M, Luo R, et al. CB1R-stabilized NLRP3 inflammasome drives antipsychotics cardiotoxicity. Signal Transduct Target Ther. 2022;7:1\u201315.","journal-title":"Signal Transduct Target Ther"},{"key":"2935_CR52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ni.1703","volume":"10","author":"L Franchi","year":"2009","unstructured":"Franchi L, Eigenbrod T, Mu\u00f1oz-Planillo R, Nu\u00f1ez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10:241\u20137.","journal-title":"Nat Immunol"},{"key":"2935_CR53","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/FJC.0000000000000694","volume":"74","author":"A Rauf","year":"2019","unstructured":"Rauf A, Shah M, Yellon DM, Davidson SM. Role of caspase 1 in ischemia\/reperfusion injury of the myocardium. J Cardiovasc Pharmacol. 2019;74:194\u2013200.","journal-title":"J Cardiovasc Pharmacol"},{"key":"2935_CR54","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejphar.2008.06.088","volume":"592","author":"J-F Wang","year":"2008","unstructured":"Wang J-F, Min J-Y, Hampton TG, Amende I, Yan X, Malek S, et al. Clozapine-induced myocarditis: role of catecholamines in a murine model. Eur J Pharmacol. 2008;592:123\u20137.","journal-title":"Eur J Pharmacol"},{"key":"2935_CR55","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1159\/000445572","volume":"38","author":"X Hu","year":"2016","unstructured":"Hu X, Ma R, Lu J, Zhang K, Xu W, Jiang H, et al. IL-23 promotes myocardial I\/R injury by increasing the inflammatory responses and oxidative stress reactions. Cell Physiol Biochem. 2016;38:2163\u201372.","journal-title":"Cell Physiol Biochem"},{"key":"2935_CR56","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1161\/hc5001.100629","volume":"104","author":"M Afanasyeva","year":"2001","unstructured":"Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, et al. Interleukin-12 receptor\/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-\u03b3\u2013independent pathway. Circulation. 2001;104:3145\u201351.","journal-title":"Circulation"},{"key":"2935_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4330\/wjc.v11.i10.221","volume":"11","author":"N Jimenez-Tellez","year":"2019","unstructured":"Jimenez-Tellez N, Greenway SC. Cellular models for human cardiomyopathy: what is the best option? World J Cardiol. 2019;11:221.","journal-title":"World J Cardiol"},{"key":"2935_CR58","first-page":"e000043","volume":"11","author":"K Musunuru","year":"2018","unstructured":"Musunuru K, Sheikh F, Gupta RM, Houser SR, Maher KO, Milan DJ, et al. Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the american heart association. Circ Genom Precis Med. 2018;11:e000043.","journal-title":"Circ Genom Precis Med"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02935-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02935-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:21:16Z","timestamp":1757143276000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-025-02935-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2935"],"URL":"https:\/\/doi.org\/10.1038\/s41380-025-02935-z","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]},"assertion":[{"value":"8 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CAB is founder of Sequence2Script Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}